Table 2.
Univariate analysis performed on 135 VM patients. N.B. Localization was studied for 141 VMs, as 6 patients had VMs affecting 2 localizations
| DD*<500 | DD*>500 | p-value | |
|---|---|---|---|
| Sex | |||
|
|
|||
| Male | 22(51%) | 21(49%) | 0.190 |
| Female | 58(63%) | 34(37%) | |
|
|
|||
| Medium age (± st dev) | 28(±16) | 25(±17) | 0.480 |
|
|
|||
| Localization | |||
|
|
|||
| Head and neck | 36(69%) | 16(31%) | 0.060 |
| Trunk | 5(26%) | 14(74%) | 0.002 |
| Limbs | 39(56%) | 31(44%) | 0.380 |
|
|
|||
| Surface | <0.001 | ||
|
|
|||
| <10cm2 | 53(77%) | 16(23%) | |
| >10cm2 | 27(41%) | 39(59%) | |
|
|
|||
| Aspect | 0.340 | ||
|
|
|||
| Flat | 53(62%) | 32(38%) | |
| Raised | 27(54%) | 23(46%) | |
|
|
|||
| Color | 0.458 | ||
|
|
|||
| Blue | 53(62%) | 33(38%) | |
| Skin color | 27(55%) | 22(45%) | |
|
|
|||
| Palpable phlebolith(s) | <0.001 | ||
|
|
|||
| No | 58(73%) | 21(27%) | |
| Yes | 22(39%) | 34(61%) |